Press release
Drug Eluting Stent Market worth $14.94 billion by 2030, growing at a CAGR of 10.82% - Exclusive Report by 360iResearch
Drug Eluting Stent Market | 360iResearch
The Global Drug Eluting Stent Market to grow from USD 6.57 billion in 2022 to USD 14.94 billion by 2030, at a CAGR of 10.82%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/drug-eluting-stent?utm_source=openpr&utm_medium=referral&utm_campaign=sample
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Drug Eluting Stent Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Drug Eluting Stent Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Drug Eluting Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Arkray, Inc., B. Braun, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical LLC, HEXACATH, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical LLC, Shandong JW Medical Systems LTD., and Terumo Corporation.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/drug-eluting-stent?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Drug Eluting Stent Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Drug Coating, market is studied across Polymer Free Coatings and Polymer-Based Coatings. The Polymer Free Coatings is further studied across Micro Porous Surface, Micro Structured Surface, Nanoporous Surface, and Slotted Tubular Surface. The Polymer-Based Coatings is further studied across Biodegradable Polymers and Non-Biodegradable Polymers. The Polymer Free Coatings is projected to witness significant market share during forecast period.
Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease. The Peripheral Artery Disease is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Drug Eluting Stent Market, by Drug Coating
7. Drug Eluting Stent Market, by Application
8. Americas Drug Eluting Stent Market
9. Asia-Pacific Drug Eluting Stent Market
10. Europe, Middle East & Africa Drug Eluting Stent Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Drug Eluting Stent Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Drug Eluting Stent Market?
3. What is the competitive strategic window for opportunities in the Drug Eluting Stent Market?
4. What are the technology trends and regulatory frameworks in the Drug Eluting Stent Market?
5. What is the market share of the leading vendors in the Drug Eluting Stent Market?
6. What modes and strategic moves are considered suitable for entering the Drug Eluting Stent Market?
Read More @ https://www.360iresearch.com/library/intelligence/drug-eluting-stent?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Eluting Stent Market worth $14.94 billion by 2030, growing at a CAGR of 10.82% - Exclusive Report by 360iResearch here
News-ID: 3276967 • Views: …
More Releases from 360iResearch
Electrochromic Glass & Devices Market worth $9.59 billion by 2030, growing at a …
The "Electrochromic Glass & Devices Market by Products (Displays, Mirrors, Windows), Materials (Organic Compounds, Transition Metal Oxides), Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/electrochromic-glass-devices?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Electrochromic (EC) glass, known also as smart or switchable glass, changes light transmission properties with an applied voltage, transitioning between transparent and opaque states through electrochemical reactions. The market for EC glass includes various types…
Immunochemicals Market worth $4.75 billion by 2030, growing at a CAGR of 7.19% - …
The "Immunochemicals Market by Product (Antibodies, Cytokines & Chemokines, Immunoglobulins), Source (Animal-Derived, Synthetic), Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/immunochemicals?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Immunochemicals are biochemical substances, including antibodies, antigens, conjugates, and enzymes, utilized in diagnostics, therapeutics, and research, leveraging the immune system's protein-binding ability. Essential for accurate disease diagnostics, developing targeted therapies, and research in disease mechanisms, their applications span clinical…
Farming As A Service Market worth $7.36 billion by 2030, growing at a CAGR of 16 …
The "Farming As A Service Market by Process (Access To Markets, Farm Management Solutions, Production Assistance), Type (Crop, Livestock), Delivery Model, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/farming-as-a-service?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Farming As A Service (FaaS) is a business model offering farm management solutions through subscription or pay-per-use mechanisms, encompassing precision farming, consultancy, crop monitoring, and equipment rentals. These services leverage advancements in…
Torpedo Market worth $1.59 billion by 2030, growing at a CAGR of 5.91% - Exclusi …
The "Torpedo Market by Weight (Heavy-Weight Torpedoes, Light-Weight Torpedoes), Launch Platform (Air-Launched, Sea-Launched) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/torpedo?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The torpedo market, comprising a broad range of underwater self-propelled weapons designed for launch from submarines, surface vessels, aircraft, and unmanned platforms, is expected to see significant growth driven by escalating defense budgets and technological advancements. Torpedoes, integral to modern naval…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
